Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,619 across all filing types
Latest filing 2014-06-10 Director's Dealing
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
103年05月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company directors and executives. There is no indication of financial statements, earnings data, or report announcements. The document is not a general regulatory filing or a report publication announcement but a specific disclosure of insider share transactions and holdings. Therefore, the document fits the category of Director's Dealing (DIRS).
2014-06-10 Chinese
103年05月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It lists their shareholdings at appointment and current holdings, as well as pledged shares and related ratios. The document is titled with the company name and appears to be a disclosure of insider shareholdings and pledges. There is no indication of a meeting, financial results, audit, or other report types. The content is focused on insider shareholding information, which aligns with Director's Dealing filings that report personal share transactions or holdings by company directors and executives. The document length is 2486 characters, which is relatively short but contains substantive data on insider holdings rather than just an announcement. Therefore, the best fitting category is Director's Dealing (DIRS).
2014-06-10 Chinese
103年5月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a revenue summary report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes and explanatory notes. It is a brief financial data summary without detailed financial statements or comprehensive analysis. The document length is short (788 characters), and it does not contain full financial reports or management discussion. It is essentially a factsheet or summary of key financial figures for a specific period (May 2014). Therefore, it fits best into the category of Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2014-06-10 Chinese
103年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 景岳, providing information about fund loans and endorsement guarantees for the current and previous months, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. It does not contain any narrative, management discussion, or comprehensive financial data. It appears to be a regulatory disclosure or compliance update rather than a full report. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2014-06-10 Chinese
103年06月內部人持股未轉讓(事前)
Director's Dealing Classification · 95% confidence The document is a short tabular report showing a director's related party (spouse) shareholding transaction details, including untransferred shares and reasons. It involves a director's spouse and shareholding data, which fits the definition of Director's Dealing (DIRS). The document length is very short (405 characters), but it contains specific insider share transaction data, not just an announcement or certification. Therefore, it is classified as DIRS with high confidence.
2014-06-09 Chinese
103年04月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, which is characteristic of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document length is over 10,000 characters, indicating it is a full report rather than a brief announcement. Therefore, the document is best classified as a Director's Dealing report.
2014-05-14 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.